Combined type-1 plasminogen activator inhibitor and NOD2/CARD15 genotyping predicts complicated Crohn's disease behaviourALVAREZ-LOBOS, M; AROSTEGUI, J. I; SANS, M et al.Alimentary pharmacology & therapeutics. 2007, Vol 25, Num 4, pp 429-440, issn 0269-2813, 12 p.Article

Behcet's disease and hereditary periodic fever syndromes : Casual association or causal relationship ?ESPINOSA, G; AROSTEGUI, J. I; PLAZA, S et al.Clinical and experimental rheumatology (Testo stampato). 2005, Vol 23, Num 4, pp S.64-S.66, issn 0392-856X, SUP38Article

A sporadic case of early-onset sarcoidosis resembling Blau syndrome due to the recurrent R334W missense mutation on the NOD2 geneCOTO-SEGURA, P; MALLO-GARCIA, S; COSTA-ROMERO, M et al.British journal of dermatology (1951). 2007, Vol 157, Num 6, pp 1257-1259, issn 0007-0963, 3 p.Article

Neutropenia congénita grave: análisis de las características clínicas, estudios diagnósticos, tratamiento y seguimiento a largo plazo = Severe congenital neutropenia: analysis of clinical features, diagnostic methods, treatment and long-term outcomeMILA, M; RUFACH, A; DAPENA, J. L et al.Anales de pediatria (2003. Ed. impresa). 2011, Vol 75, Num 6, pp 396-400, issn 1695-4033, 5 p.Article

Possible association between NOD2 variants and joint surgery in psoriatic arthritisGRAELL, E; AROSTEGUI, J. I; SANMARTI, R et al.Clinical and experimental rheumatology (Testo stampato). 2010, Vol 28, Num 1, pp 30-34, issn 0392-856X, 5 p.Article